Serum Metabolomics Reveals Carnitine Metabolism as a Possible Central Metabolic Axis of Pemafibrate Action
International Journal of Molecular Sciences · 14.07.2026 · 27 (14) · 6252
DOI: 10.3390/ijms27146252 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.07.2026. Verfasst von Chufang Qian und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Medical Research Promotion, Shinshu University Graduate School of Medicine, Matsumoto 390-8621, Japan. Hauptthemen laut MEDLINE: Carnitine, Metabolomics, Metabolome, Butyrates. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shinshu Public Utility Foundation for Promotion of Medical Sciences, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Pemafibrate (PEM), a novel selective peroxisome proliferator-activated receptor α modulator, is widely used to treat dyslipidemia, yet its systemic metabolic effects remain incompletely defined. We performed untargeted serum metabolomics in patients with hypertriglyceridemia at baseline and at 2 and 8 weeks after PEM treatment. PEM increased cystine, L-methionine, uridine, and L-carnitine, while decreasing lipid-related metabolites, including lysophosphatidylcholines, adenosine, and erucic acid (22:1). Circulating carnitine levels rose progressively, with a significant elevation at 8 weeks, whereas ketone bodies showed only modest, non-significant increases. Consistently, increases in circulating and tissue carnitine were also observed in male 8-week-old C57BL/6J mice treated with a clinically relevant dose of PEM for 2 weeks. Mechanistically, PEM did not significantly alter genes involved in carnitine biosynthesis or transport, but upregulated hepatic carnitine O-acetyltransferase and carnitine O-octanoyltransferase, key enzymes of carnitine utilization and turnover. Collectively, these findings suggest that enhanced carnitine metabolism represents an important metabolic axis of PEM action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Global Medical Research Promotion, Shinshu University Graduate School of Medicine, Matsumoto 390-8621, Japan.
- Department of Clinical Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
- Postdoctoral Mobile Station of Clinical Medicine, Hebei Medical University, Shijiazhuang 050017, China.
- Department of Gastroenterology, University-Town Hospital, The Fourth Clinical College of Chongqing Medical University, Chongqing 401331, China.
- Medical Solution Promotion Department, Medical Solution Segment, LSI Medience Corporation, Tokyo 174-8555, Japan.
- Kyushu Professional Search Limited Liability Partnership, Fukuoka 819-0388, Japan.
ORCID-Profile: Kazuhiro Tanabe, Chihiro Hayashi, Qianqian Zheng, Jiali Chen, Takero Nakajima, Takanobu Iwadare, Takefumi Kimura, Naoki Tanaka
Förderung
- Shinshu Public Utility Foundation for Promotion of Medical Sciences
- Japan Agency for Medical Research and Development
Zitieren
APA
Qian, C., Zhang, X., Zhang, Z., Tanabe, K., Hayashi, C., Kittaka, H., Zheng, Q., Chen, J., Yuki, S., Yang, X., Diao, Y., Nakajima, T., Iwadare, T., Kimura, T., Nakamuta, M., & Tanaka, N. (2026). Serum Metabolomics Reveals Carnitine Metabolism as a Possible Central Metabolic Axis of Pemafibrate Action. International Journal of Molecular Sciences, 27(14), 6252. https://doi.org/10.3390/ijms27146252
Vancouver
Qian C, Zhang X, Zhang Z, Tanabe K, Hayashi C, Kittaka H, et al. Serum Metabolomics Reveals Carnitine Metabolism as a Possible Central Metabolic Axis of Pemafibrate Action. International Journal of Molecular Sciences. 2026;27(14):6252. doi:10.3390/ijms27146252
BibTeX
@article{Qian2026,
author = {Qian, Chufang and Zhang, Xuguang and Zhang, Zhe and Tanabe, Kazuhiro and Hayashi, Chihiro and Kittaka, Hiroki and Zheng, Qianqian and Chen, Jiali and Yuki, Sakura and Yang, Xiyue and Diao, Yifan and Nakajima, Takero and Iwadare, Takanobu and Kimura, Takefumi and Nakamuta, Makoto and Tanaka, Naoki},
title = {Serum Metabolomics Reveals Carnitine Metabolism as a Possible Central Metabolic Axis of Pemafibrate Action},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6252},
doi = {10.3390/ijms27146252}
}
EUVIMED